Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 3 studies | 24% ± 3% | |
GABAergic neuron | 3 studies | 31% ± 4% | |
interneuron | 3 studies | 30% ± 10% |
Insufficient scRNA-seq data for expression of GLYATL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 85% | 196.76 | 391 / 459 | 72% | 57.85 | 800 / 1118 |
prostate | 94% | 81.42 | 230 / 245 | 55% | 3.84 | 277 / 502 |
brain | 85% | 27.62 | 2246 / 2642 | 40% | 2.03 | 280 / 705 |
kidney | 73% | 20.11 | 65 / 89 | 35% | 1.56 | 316 / 901 |
skin | 93% | 84.46 | 1685 / 1809 | 6% | 0.24 | 29 / 472 |
esophagus | 64% | 35.50 | 926 / 1445 | 17% | 1.77 | 32 / 183 |
uterus | 39% | 11.54 | 67 / 170 | 31% | 11.74 | 144 / 459 |
bladder | 57% | 13.81 | 12 / 21 | 6% | 1.86 | 32 / 504 |
heart | 63% | 15.40 | 543 / 861 | 0% | 0 | 0 / 0 |
adipose | 50% | 13.63 | 596 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 48% | 12.00 | 643 / 1335 | 0% | 0 | 0 / 0 |
spleen | 48% | 7.66 | 116 / 241 | 0% | 0 | 0 / 0 |
stomach | 43% | 7.57 | 156 / 359 | 4% | 1.39 | 12 / 286 |
intestine | 43% | 8.03 | 416 / 966 | 3% | 0.21 | 16 / 527 |
thymus | 43% | 8.54 | 280 / 653 | 1% | 0.18 | 8 / 605 |
lung | 12% | 2.47 | 67 / 578 | 29% | 6.99 | 331 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 33% | 8.96 | 15 / 45 |
adrenal gland | 8% | 1.65 | 20 / 258 | 23% | 0.86 | 52 / 230 |
ovary | 7% | 1.33 | 13 / 180 | 20% | 4.61 | 86 / 430 |
lymph node | 0% | 0 | 0 / 0 | 21% | 3.57 | 6 / 29 |
pancreas | 9% | 3.03 | 31 / 328 | 8% | 0.64 | 15 / 178 |
peripheral blood | 17% | 6.62 | 155 / 929 | 0% | 0 | 0 / 0 |
muscle | 14% | 2.14 | 112 / 803 | 0% | 0 | 0 / 0 |
liver | 9% | 1.44 | 21 / 226 | 2% | 0.07 | 7 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042758 | Biological process | long-chain fatty acid catabolic process |
GO_0051793 | Biological process | medium-chain fatty acid catabolic process |
GO_1903965 | Biological process | monounsaturated fatty acid catabolic process |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005739 | Cellular component | mitochondrion |
GO_0047961 | Molecular function | glycine N-acyltransferase activity |
Gene name | GLYATL2 |
Protein name | Glycine N-acyltransferase-like protein 2 (EC 2.3.1.13) (Acyl-CoA:glycine N-acyltransferase-like protein 2) |
Synonyms | |
Description | FUNCTION: Mitochondrial acyltransferase which transfers the acyl group to the N-terminus of glycine . Conjugates numerous substrates, such as arachidonoyl-CoA and saturated medium and long-chain acyl-CoAs ranging from chain-length C8:0-CoA to C18:0-CoA, to form a variety of N-acylglycines. Shows a preference for monounsaturated fatty acid oleoyl-CoA (C18:1-CoA) as an acyl donor. Does not exhibit any activity toward C22:6-CoA and chenodeoxycholoyl-CoA, nor toward serine or alanine . . |
Accessions | ENST00000287275.6 ENST00000532258.1 Q8WU03 |